Evidence map›Paper›PMID 37275910›Full record

ArticleFrontiers in immunology2023

M-MDSC

Arpa Aintablian, Sandra Strozniak, Marion Heuer, Manfred B Lutz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Arpa AintablianInstitute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
Sandra StrozniakInstitute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
Marion HeuerInstitute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
Manfred B LutzInstitute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
University of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid-derived suppressor cells (MDSC) represent major regulators of immune responses, which can control T cells

Indexed as

Granulocyte-Macrophage Colony-Stimulating FactorMyeloid-Derived Suppressor CellsAnimalsArginaseBone MarrowIntegrin alpha1Interleukin-3MiceArginaseGranulocyte-Macrophage Colony-Stimulating FactorIntegrin alpha1Interleukin-3bone marrowGM-CSFIL-3in vitro culturemyeloid-derived suppressor cells (MDSC)protocol

Identifiers

PMID37275910
PMCPMC10235456
OpenAlexW4377137321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.